Lebrikizumab
Modify Date: 2024-01-09 11:49:30
Lebrikizumab structure
|
Common Name | Lebrikizumab | ||
|---|---|---|---|---|
| CAS Number | 953400-68-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LebrikizumabLebrikizumab is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab can be used for the research of asthma[1]. |
| Name | Lebrikizumab |
|---|
| Description | Lebrikizumab is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab can be used for the research of asthma[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |